About Company
- Legal Name: Hubei Biocause Heilen Pharmaceutical Co., Ltd
- Registered country: China
- Address: C-7th Floor, Golden trade center, Guantong Garden, 115 Wujiadun Road, Jianghan...
- Number of employees: 1000 - 4999
- Established year: 1993
Description:
Hubei Biocause Pharma is a leading API producer in China with two API sites and one R&D center, inspected and approved 9 times by the US FDA and 3 times under EU GMP. The company produces abiraterone acetate, ibuprofen, milrinone, fludarabine phosphate, granisetron HCl, flumazenil, ibuprofen arginine, ibuprofen lysinate, dexibuprofen, cladribine, carfilzomib, torasemide, dexmedetomidine HCl, docusate sodium and indocyanine green, exporting to more than 90 countries, with about half sold into regulated markets such as the USA and EU.
Business Activities
Active Pharmaceutical Ingredients (APIs)
Manufacturer
Contract & Outsourcing Services
Manufacturer
ATC (Anatomical Therapeutic Chemical) Classification
Manufacturer
Innovator APIs
Manufacturer
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Ibuprofen, Ibuprofen Arginine, Carfilzomib, Fludarabine Phosphate, MILRINONE, Dexibuprofen, Torsemide
- Finished Dosage Forms: Ibuprofen Arginine Granules, Torsemide tablets
- Pharma Chemicals: Abiraterone acetate, Granisetron Hydrochloride
- Contract Research Organisations Services (CROs): CDMO Services
Our Products & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
ISO 17020
DMF
FDA
GMP
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment